Please login to the form below

Not currently logged in
Email:
Password:

immunotherapy

This page shows the latest immunotherapy news and features for those working in and with pharma, biotech and healthcare.

Liver cancer failure dents Opdivo potential by $1bn, says analyst

Liver cancer failure dents Opdivo potential by $1bn, says analyst

Then, in a double-whammy for the company, it was forced to report a failure for its flagship cancer immunotherapy Opdivo (nivolumab) in first-line liver cancer, which William Blair had

Latest news

More from news
Approximately 80 fully matching, plus 417 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 4 fully matching, plus 48 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 43 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 11 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...
MIT reveals new pill to deliver insulin
A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team...
Fearless Girl cover
25 Women Leaders in UK Healthcare
Women trailblazers helping to shape the future of healthcare (Part 1)...

Infographics